New drug offers hope for rare joint tumor patients unable to have surgery
Disease control
Ongoing
This study tests an investigational drug called emactuzumab for people with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous growth in the joints that can cause pain and stiffness. The trial includes 128 participants who cannot have surgery to remove the tumor. Half re…
Phase: PHASE3 • Sponsor: SynOx Therapeutics Limited • Aim: Disease control
Last updated May 13, 2026 16:02 UTC